← Leaderboards
Christine Elizabeth Canman
St. Jude Children'S Research Hospital
$3,206,622
Attributed
$3,206,622
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $314.9K · FY2008–18$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,206,622 · 2
By mechanism
R01$3,206,622 · 2
Top collaborators
No co-investigators on record.
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Mary-Ann Bjornsti$8,611,236
- Philip M Potter$7,971,270
- Linda M Hendershot$7,381,128
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularNeoplastic CellDna Polymerase ZetaLeadLesionMalignant NeoplasmsDna-Directed Dna PolymeraseDna LesionDna RepairInhibitor/AntagonistAntineoplastic AgentsDesignAffectCrosslinkChromosome AbnormalityDna BiosynthesisBaseDna Interstrand CrosslinkingCatalytic DomainComplexCisplatinHomologous RecombinationCellsPathway Interactions
Grant awards (11)
Novel mechanisms by which REV1 and POLZ affect response to anticancer agents$313,875
R01 · FY2018 · CA · contact PI
Novel mechanisms by which REV1 and POLZ affect response to anticancer agents$313,875
R01 · FY2017 · CA · contact PI
Novel mechanisms by which REV1 and POLZ affect response to anticancer agents$313,875
R01 · FY2016 · CA · contact PI
Novel mechanisms by which REV1 and POLZ affect response to anticancer agents$314,213
R01 · FY2015 · CA · contact PI
Novel mechanisms by which REV1 and POLZ affect response to anticancer agents$314,888
R01 · FY2014 · CA · contact PI
Novel Mechanisms by which RAD18 and POLZ affect Response to Anticancer Agents$275,345
R01 · FY2012 · CA · contact PI
Novel Mechanisms by which RAD18 and POLZ affect Response to Anticancer Agents$275,345
R01 · FY2011 · CA · contact PI
Novel Mechanisms by which RAD18 and POLZ affect Response to Anticancer Agents$283,860
R01 · FY2010 · CA · contact PI
Novel Mechanisms by which RAD18 and POLZ affect Response to Anticancer Agents$283,860
R01 · FY2009 · CA · contact PI
Novel Mechanisms by which RAD18 and POLZ affect Response to Anticancer Agents$283,860
R01 · FY2008 · CA · contact PI
MOLECULAR MECHANISMS OF MAMMALIAN CHECKPOINT PATHWAYS$233,626
R01 · FY2000 · CA